Showing results (1991-2000 of 8,257) with videos related to
Sort By:
Pageof 826
Haematologica|August 18, 2026
Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complicationsCaitlin Unkenholz, Sofía Huerga, Alison Moskowitz, et al.Haematologica|August 18, 2026
A novel KMT2A::AFF1-derived fusion circRNA regulates mitochondrial metabolism in t(4;11) B-cell acute lymphoblastic leukemiaDoron Tolomeo, Michela Bardini, Santina Venuto, et al.Haematologica|August 20, 2026
Venetoclax-azacitidine treatment in TTMV::RARA-driven acute myeloid leukemia mimicking acute promyelocytic leukemiaLu Zhao, Zhanwang Zhu, Bihui Yang, et al.Haematologica|August 20, 2026
Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratificationAndrew F Berdel, Christoph Röllig, Clara Burkhard-Meier, et al.Haematologica|August 20, 2026
Navigating murky waters: risk scores for nodular lymphocyte-predominant Hodgkin lymphomaEmily J Smith, Michael Sargent BinkleyHaematologica|July 23, 2026
Rapid recovery and functional resilience of bone marrow function post B-cell acute lymphoblastic leukemiaChristina T Jensen, Erik Hultin, Stefan Lang, et al.Haematologica|September 24, 2026
Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab eraJonathan R Day, Melissa C Larson, Carla Casulo, et al.Haematologica|September 24, 2026
DLBCL2IDCS: transdifferentiation of diffuse large B-cell lymphoma to interdigitating dendritic cell sarcomaKylie Rose Everard, Mark Anthony Turingan, Ingrid Tam, et al.Haematologica|September 24, 2026
Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD"Annamaria Vincenzi, Marco PicardiHaematologica|September 10, 2026
Does it really have to hurt? All-oral treatment for acute myeloid leukemiaChristoph Rummelt, Michael LübbertPageof 826